A Functionally Robust Phenotypic Screen that Identifies Drug Resistance-associated Genes Using 3D Cell Culture

Area of Science:

• Oncology
• Molecular Biology
• Drug Discovery

Background:

• Drug resistance, particularly to EGFR tyrosine kinase inhibitors (TKI), is a significant challenge in cancer therapy.
• Traditional 2D cell culture assays for drug resistance lack physiological relevance and do not accurately predict in vivo outcomes.
• Identifying novel targets and understanding resistance mechanisms are crucial for improving cancer treatment efficacy.

Purpose of the Study:

• To develop and validate a physiologically relevant 3D cell culture model for identifying drug resistance mechanisms.
• To discover novel therapeutic targets and intermediates involved in oncogenic signaling pathways contributing to drug resistance.
• To establish a phenotype-based genetic screen for evaluating drug resistance in cancer.

Main Methods:

• A genetic screen utilizing a 3D cell culture model with functional endpoints was developed.
• The assay was performed over 1-1.5 months using a small cDNA library.
• Phenotypic changes in response to drug treatment were analyzed to identify resistance mechanisms.

Main Results:

• The 3D culture assay successfully identified five unknown intermediates in the EGFR and PI3K signaling pathways.
• One novel molecule's role in drug resistance was characterized, demonstrating the assay's potential.
• The screening method provides a foundation for high-throughput screening of oncogenic signaling pathways.

Conclusions:

• The developed 3D culture assay is a powerful tool for discovering novel drug resistance mechanisms and therapeutic targets.
• This approach offers a more physiologically relevant alternative to traditional 2D assays for cancer research.
• The methodology can be expanded for high-throughput screening to accelerate drug discovery and development in oncology.